Registry to collect data on mycobacterial infections in Austria
Mycobacteria Registry Study: Prospective Observational Study in Austria
This study is collecting information from patients in Austria with mycobacterial infections to see how their treatment goes and what factors might affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ludwig Boltzmann Institute for Lung Health Academic / other |
| Locations | 3 sites (Vienna and 2 other locations) |
| Trial ID | NCT06522347 on ClinicalTrials.gov |
What this trial studies
This observational registry study aims to systematically gather epidemiological and clinical data on patients diagnosed with Mycobacterium tuberculosis and non-tuberculous mycobacterial infections in Austria. The study will document the natural course of treatment without additional interventions, focusing on understanding the risk factors for mortality associated with these infections. Data will be collected from participants who are already receiving standard medical care for their conditions, allowing researchers to analyze treatment effectiveness over time.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacterial infections.
Not a fit: Patients who do not comprehend the study or cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the risk factors affecting mortality in patients with mycobacterial infections, potentially leading to improved treatment strategies.
How similar studies have performed: While this study is observational and focuses on data collection, similar studies have shown success in understanding treatment outcomes for infectious diseases, suggesting that this approach could yield meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection * individuals aged 18 years or older * written informed consent Exclusion Criteria: * to not comprehend and rightfully judge participation
Where this trial is running
Vienna and 2 other locations
- Klinik Hietzing — Vienna, Austria (Recruiting)
- Klinik Penzing — Vienna, Austria (Recruiting)
- Ludwig Boltzmann Institut for Lung Health — Vienna, Austria (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.